Ly6g+ neutrophil-derived mir-223 inhibits the nlrp3 inflammasome in mitochondrial damp-induced acute lung injury

ABSTRACT MicroRNA (miRNA) mediates RNA interference to regulate a variety of innate immune processes, but how miRNAs coordinate the mechanisms underlying acute lung injury/acute respiratory

distress syndrome (ALI/ARDS) in patients with pulmonary inflammatory injury is still unknown. In this study, we demonstrated that miR-223 limits the number of Ly6G+ neutrophils and inhibits

the activity of the NLRP3 inflammasome to alleviate ALI induced by mitochondrial damage-associated molecular patterns (DAMPs) (MTDs). miR-223 expression is increased in the lungs of

MTD-induced mice or ARDS patients following trauma/transfusion or following the physiological remission of ALI/ARDS. miR-223−/+ mice exhibited more severe ALI and cytokine dysregulation.

Other studies have shown that MTD-induced increases in miR-223 expression are mainly contributed by Ly6G+ neutrophils from the haematopoietic system. miR-223 blocks bone marrow-derived Ly6G+

neutrophil differentiation and inhibits peripheral cytokine release. In addition, MTD-induced miR-223 expression activates a negative feedback pathway that targets the inhibition of NLRP3

expression and IL-1_β_ release; therefore, miR-223 deficiency can lead to the sustained activation of NLRP3-IL-1_β_. Finally, elimination of peripheral Ly6G+ neutrophils and pharmacological

blockade of the miR-223–NLRP3–IL-1_β_ signalling axis could alleviate MTD-induced ALI. In summary, miR-223 is essential for regulating the pathogenesis of DAMP-induced ALI. SIMILAR CONTENT

BEING VIEWED BY OTHERS NUCLEAR SPHK2/S1P INDUCES OXIDATIVE STRESS AND NLRP3 INFLAMMASOME ACTIVATION VIA PROMOTING P53 ACETYLATION IN LIPOPOLYSACCHARIDE-INDUCED ACUTE LUNG INJURY Article Open

access 18 January 2023 MIRNA-206-3P ALLEVIATES LPS-INDUCED ACUTE LUNG INJURY VIA INHIBITING INFLAMMATION AND PYROPTOSIS THROUGH MODULATING TLR4/NF-ΚB/NLRP3 PATHWAY Article Open access 24

May 2024 SUPPRESSION OF LNCRNA NLRP3 INHIBITS NLRP3-TRIGGERED INFLAMMATORY RESPONSES IN EARLY ACUTE LUNG INJURY Article Open access 01 October 2021 MAIN Acute lung injury/acute respiratory

distress syndrome (ALI/ARDS) is a respiratory disease characterized by diffuse alveolar injury, oedema, bleeding, the formation of a transparent membrane and polymorphonuclear neutrophil

infiltration.1 ARDS is a more serious form of ALI and is characterized by a rapid onset, poor prognosis and high mortality; it is one of the major causes of death in intensive care units

worldwide.2, 3, 4, 5, 6 Although the clinical risk factors of ARDS has been elucidated, it is difficult for clinicians to assess the clinical risk factors and predict the survival and

progression of ARDS. The pathology of ARDS, especially non-pulmonary ARDS (caused by trauma, blood transfusion and transplantation), is still difficult to articulate as it involves complex

genetic, environmental and immune interactions. Pattern recognition receptor (PRR) is a membrane-bound or cytoplasmic receptor that recognizes exogenous components known as

pathogen-associated molecular patterns (PAMPs) and endogenous damage-associated molecular patterns (DAMPs). PRR is essential for innate immunity. Toll-like receptors (TLRs) function as

membrane-bound immune PRRs, and a variety of functional human TLRs have been identified.7 The development of infectious or pulmonary ALI/ARDS is related to activation of the TLR signalling

pathway. Hyaluronic acid produced by tissue injury is mediated by TLR2/4, which contributes to the development of ARDS.8 Endotoxin release from Gram-negative bacteria is mediated by TLR4.9

In addition, TLR3 mediates hyperoxia-induced ARDS,10 whereas TLR2 mediates bleeding-induced ARDS.11 In addition to membrane-bound PRRs, the PRRs in the cytoplasm, such as the NLRP3

inflammasome, can recognize PAMPs and DAMPs indirectly. This process can be referred to as the detection of homeostasis-altering molecular processes. The NLRP3 inflammasome is composed of

NLRP3, ASC and caspase-1. When NLRP3 inflammasomes recognize PAMPs and DAMPs, caspase-1 cleaves pro-IL-1_β_ and pro-IL-18, producing active IL-1_β_ and IL-18, thereby mediating multiple

inflammatory responses.12, 13 Studies have shown that NLRP3 is highly associated with trauma- and transfusion-induced ARDS, and traumatic/surgical injuries release tissue-derived

mitochondrial DAMPs (MTDs) into circulation to activate NLRP3 inflammasomes in neutrophils.14 Transfusion also produces circulating MTDs.15 MTDs include mitochondrial DNA, formyl peptides

and cardiolipin, which induce DAMPs during lung endothelial cell injury.16, 17, 18 Mitochondria-targeted inhibitors have been shown to reduce DAMP-induced damage in mice mouse lung

endothelial cells.19 MTDs may be a direct cause of aseptic inflammation and clinical symptoms in non-pulmonary ARDS.20 Therefore, research on MTD-mediated injury is necessary for the

development of non-pulmonary ARDS awareness and treatment strategies. MicroRNAs (miRNAs) have a vital role in the maintenance of immune homeostasis.21, 22, 23 However, the regulation of

miRNA in ARDS also lacks effective understanding. miRNA-223 was the first miRNA to be specifically identified in the haematopoietic system,24 and it regulates natural immune homeostasis and

_Mycobacterium tuberculosis_-induced stress responses.21, 25 miR-223 is induced during myeloid differentiation and is regulated by a variety of genes.24 In addition, miR-223 regulates

NF-_κ_B-dependent macrophage differentiation,26 E2F1-dependent granulocyte differentiation,27 inflammation, infection and tumour progression.28 Several experiments have demonstrated that

miR-223 represses NLRP3 inflammatory bodies; however, the role of miR-223 in NLRP3-mediated non-pulmonary ARDS has not been studied. RESULTS MIR-223 PARTICIPATES IN MTD-INDUCED ARDS We

screened patients with acute ARDS based on the Berlin definition29 and selected those with ARDS caused by primary pneumonia, trauma, blood transfusion and inhalation. A total of 29 miRNAs

that are highly associated with the inflammatory response were detected as described by Chen _et al._30 As shown in Supplementary Figure S1A, miR-223 expression was the highest in

bronchoalveolar lavage fluid (BALF) from patients with ARDS caused by trauma and blood transfusion. qPCR was used to detect the expression level of miR-223. The results are shown in Figure

1a. The expression of miR-223 of patients with ARDS caused by trauma and blood transfusion was significantly upregulated, whereas ARDS caused by infection and inhalation remained unchanged.

In addition, we analysed the relationship between miR-223 levels from the acute period of ARDS and ΔPaO2/FiO2, using the PaO2/FiO2 difference before and after 4 days of positive

end-expiratory pressure (PEEP) treatment as a prognostic index. The results are shown in Supplementary Figure S1B. There is a linear relationship between has-miR-223 and ΔPaO2/FiO2 compared

with the control group. In other words, routine treatment will be more effective among ARDS patients with higher has-miR-223 expression. The mouse model of ARDS was induced by an intravenous

injection of MTDs, and the results are shown in Figures 1b–d. Following the induction by MTDs, the PaO2/FiO2 of mice was significantly decreased, the proportion of lung wet weight was

increased and the number of inflammatory cells in the lung was increased. Compared with the wild-type (WT) group, miR-223−/+ mice exhibited more serious MTD-induced lung injury; thus the

recovery from lung injury was delayed. Figure 1e shows that miR-223 expression began to increase in WT mice 48 h after MTD stimulation, which was later than the induction of ALI by MTDs.

miR-223 expression in miR-223−/+ mice was lower than that in WT mice and had no obvious effect on MTDs. Histological results, as shown in Figure 1f, indicate that the lung injury and

inflammation in the miR-223−/+ mouse lungs was greater than that in the WT mice 4 days after induction by MTDs. This evidence suggests that miR-223 deficiency aggravates MTD-induced ALI.

HAEMATOPOIETIC CELL-DERIVED MIR-223 RELIEVES MTD-INDUCED ALI In this study, the miR-223−/+ mice were knockout heterozygous mice, and it is unknown whether miR-223 deficiency in the lung or

blood causes the increase in lung injury. To solve this problem, we constructed bone marrow (BM) chimeric mice lung injury model. The results are shown in Figure 2a. Both WT and miR-223−/+

mice that received BM cells from miR-223−/+ mice were sensitive to MTD-induced lung injury after excessive exposure to X-ray, whereas BM cells from WT mice were insensitive to MTD induction.

This indicated that MTD-induced lung injury is mediated by the haematopoietic system. In addition, WT and miR-223−/+ mice acquired the opposite phenotype after transplantation with the

other’s BM, including the PaO2/FiO2 (Figure 2d), lung wet/dry weight ratio (Figure 2e) and the number of inflammatory cells in the lungs (Figure 2c). Meanwhile, Figure 2b shows that miR-223

expression in WT mice that received miR-223−/+ mouse BM cells was significantly lower than that in miR-223−/+ mice transplanted with WT mouse BM cells. These results indicate that miR-223

deficiency in haematopoietic-derived cells leads to aggravated MTD-induced lung injury in mice. MIR-223 FROM LY6G+ NEUTROPHILS The proportion of myeloid cells in the BALF of ARDS patients

was detected. As shown in Supplementary Figures S2A and B, the proportion of LY6G+ neutrophils and LY6C+ monocytes in ARDS patients during the acute period was significantly increased. To

identify the major source of miR-223, we examined the myeloid cell population in WT and miR-223−/+ mouse BALF. The results are shown in Figure 3a. Three days after MTD induction, the myeloid

cells was significantly increased in miR-223−/+ mice compared with WT mice. Figure 3b shows that induction with MTDs resulted in increased myeloid cell populations in the peripheral blood

of miR-223−/+ and WT mice. It is worth noting that, both at the physiological level and MTD-induced level, the Ly6G+ cells in the peripheral blood of miR-223−/+ mice were significantly

higher than that in WT mice. Therefore, miR-223-deficiency leads to an increase in Ly6G+ cells in the peripheral blood of mice. Flow cytometry was used to sort the myeloid cells, and miR-223

were detected by qPCR. The results, which are shown in Figure 3c, indicate that miR-223 was highly expressed in the Ly6G+ cells of WT mice at levels greater than in miR-223−/+ mice after

stimulation by MTDs. These results suggest that the increase in miR-223 expression following MTD stimulation is contributed by Ly6G+ cells from the haematopoietic system. MIR-223 BLOCKS

GRANULOCYTE AND MONOCYTE PRECURSORS FROM DIFFERENTIATING INTO LY6G+ CELLS Peripheral LY6G+ cells are mainly differentiated from BM granulocyte and monocyte precursors (GMPs).31 To

investigate the effect of miR-223 on the number of LY6G+ cells, the effect of miR-223 on the differentiation of GMPs to Ly6G+ cells was examined. As shown in Figure 4a, the number of GMPs in

the miR-223−/+ mouse BM and the number of Ly6G+ cells in the peripheral blood and BALF were significantly higher and lower than those in WT mice, respectively. The percentage of Ly6G+ cells

in the peripheral blood and BALF of WT mice transplanted with miR-223−/+ mouse BM cells and miR-223−/+ mice transplanted with WT mouse BM cells was also increased and decreased,

respectively. Therefore, WT mice and miR-223−/+ mice transplanted with the other’s BM cells exhibited the opposite myeloid cell characteristics, suggesting that miR-223 inhibits the

differentiation of GMPs into Ly6G+ cells. To determine whether GMP differentiation to Ly6G+ cells is affected by the intrinsic or extrinsic need for miR-223, we generated BM chimeric mice in

which CD45.1+ WT or CD45.1+ miR-223−/+ BM cells were transferred with an equal number of CD45.2+ BM cells into lethally irradiated CD45.2+ recipients. Then, 2 weeks after transplantation,

we observed significant reductions in the frequency of GMPs derived from BM cells of CD45.1+miR-223−/+ mice (Figure 3c), indicating a cell-intrinsic defect in the differentiation of GMPs in

miR-223-deficient mice. This suggests that the differentiation of GMPs into Ly6G+ cells is caused by the increased endogenous expression of miR-223 in GMP cells. MIR-223-DEFICIENCY

AGGRAVATES MTD-INDUCED CYTOKINE DYSREGULATION To verify the role of Ly6G+ cells in mediating lung injury following MTD induction, we used antibodies to eliminate Ly6G+ and Ly6C+ cells in the

peripheral blood (Figure 5a) and subsequently evaluated MTD-induced ALI in mice. The results are shown in Figures 5b and c. Treatment with Ly6C antibody did not have beneficial effects on

MTD-induced lung injury, whereas Ly6G antibody significantly improved lung injury. The clinical data also show that there is a linear relationship between LY6G+ cells and the ΔPaO2/FiO2 in

ARDS patients (Supplementary Figure S1C), where higher proportions of LY6G+ cells in the lungs of ARDS patients during the acute period correlate with worse prognosis following conventional

therapy. At the same time, the linear relationship between miR-223 and LY6G+ cells (Figure 1e) showed that miR-223 was negatively correlated with the percentage of LY6G+ cells in the lungs

of ARDS patients. These evidence fully demonstrates that Ly6G+ cells mediate MTD-induced damages to the lung tissue. Next, we examined the release of various cytokines in the lungs. As shown

in Figure 5d, miR-223-deficient mice exhibited more severe inflammatory cytokine and chemokine dysregulation compared with WT mice, especially in the expression of IL-1_β_, IL-6 and

TNF-_α_. In addition, the release of cytokines was detected after using Ly6C and Ly6G antibodies, respectively. The Ly6G antibody could ameliorate the MTD-induced cytokine dysregulation, but

the Ly6C antibody could not ameliorate the dysregulation. Studies have shown that patients or rats with ARDS caused by trauma or surgery exhibit systemic immunosuppression.32, 33 Thus we

investigated whether systemic immunosuppression of non-pulmonary ARDS was regulated by miR-223. The results are shown in Figure 5e. Cytokine release in MTD-induced WT mice was significantly

inhibited by lipopolysaccharide stimulation, whereas cytokines in the peripheral blood of miR-223−/+ mice was significantly greater than that in the WT mice, indicating that miR-223 was a

possible cause of peripheral immunosuppression in non-pulmonary ARDS. However, additional investigation is required to confirm this finding. MIR-223 NEGATIVE FEEDBACK REGULATION INHIBITS

NLRP3 EXPRESSION IN MTD-INDUCED BM-DERIVED NEUTROPHILS IL-1_β_ is mainly activated by the NLRP3 inflammasome, and we aimed to verify whether miR-223 inhibits the activation of NLRP3. The

pGL3-luc-NLRP3 3′UTR luciferase reporter gene was constructed and the predicted 3′UTR-binding site was then deleted (Figure 6a). The NLRP3 3′UTR reporter was transfected into BM-derived

neutrophils (BMDNs), then treated with 200 ng/ml MTDs for 6 h and the luciferase activity was detected. As shown in Figure 6b, MTDs upregulated the luciferase activity from the NLRP3 3′UTR

reporter plasmid, whereas the NLRP3 3′UTRdelete plasmid was unchanged. miRNA-223 mimics or inhibitor was co-transfected into BMDNs with the NLRP3 3′UTR reporter plasmid, and the results are

shown in Figures 6c and d. miR-223 mimics attenuates BMDN luciferase activity, whereas the inhibitor slightly upregulates BMDN luciferase activity. Meanwhile, the NLRP3 3′UTRdelete did not

react to miR-223 mimics or inhibitor. In addition, Figure 6e indicates that the mimics and inhibitors attenuated and enhanced the MTD-induced NLRP3 3′UTR luciferase activity, respectively.

After performing photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation (PAR-CLIP), qPCR was used to detect the level of NLRP3 mRNA that was co-precipitated. The results

are shown in Figures 5f and g. MTDs could upregulate the enrichment of NLRP3 mRNA in RNA-induced silencing complex (RISC), whereas miR-223 mimics or inhibitors significantly upregulated or

downregulated the accumulation of NLRP3 mRNA, respectively. These experiments show that MTDs can upregulate the translation of NLRP3 _in vitro_, whereas miRNA-223 can inhibit the translation

of NLRP3 3′UTR in BMDNs. Next, we examined the effect of MTDs on the level of NLRP3 and IL-1_β_ in the BMDNs of WT and miR-223−/+ mice. The results are shown in Figures 6h–j. MTDs

time-dependently upregulated miR-223 expression in WT mouse BMDNs and downregulated NLRP3 expression. In addition, in miR-223−/+ mouse BMDNs, NLRP3 expression was slightly changed in

response to MTD induction, and correspondingly, IL-1_β_ release was significantly greater than that in WT mouse. This evidence strongly suggests that miR-223 negative feedback regulates the

expression of NLRP3 and that a miR-223 deficiency may cause NLRP3 inflammasome signal blockade in response to MTD stimulation, thus resulting in excessive production of IL-1_β_. BLOCKING

NLRP3 AND IL-1Β ALLEVIATES MTD-INDUCED ALI Finally, we demonstrated whether selective blocking of the miR-223–NLRP3–IL-1_β_ could alleviate MTD-induced ALI. miR-223−/+ mice were administered

the NLRP3 small-molecule inhibitor MCC950, the IL-1R agonist anakinra or miR-223 mimics followed by the administration of MTDs. The results are shown in Figure 7a. MCC950, anakinra and

miR-223 mimics all reduced MTD-induced ALI in miR-223−/+ mice. Figure 7b showed that Ly6C+ and Ly6G+ cells could be downregulated by MCC950, anakinra and miR-223 mimics treatment. In

addition, PaO2/FiO2 was significantly decreased (Figure 7c), and the increase in the lung dry/wet weight ratio (Figure 7d) was reversed by the application of MCC950, anakinra and miR-223

mimics. More importantly, blocking miR-223–NLRP3–IL-1_β_ could ameliorate the reduction of pulmonary cytokine release following MTD induction, as shown in Figure 7e. Clinical data also

indicate the importance of IL-1_β_ in the pathogenesis of ARDS. There was a negatively linear relationship between IL-1_β_ and ΔPaO2/FiO2 or miR-223 in ARDS patients (Supplementary Figure

S1C and F), where higher levels of IL-1_β_ during the acute phase correlated with worse prognosis following conventional therapy. This evidence suggests that targeted molecular inhibition or

pharmacological blockade of NLRP3 expression and IL-1_β_ activity can effectively alleviate MTD-induced ALI. DISCUSSION Although ARDS occurs locally in the lungs, it is a systemic

inflammatory disease involving both the lungs and other circulatory organs. Traumatic brain injury,33 sepsis34 and burns35 are risk factors for ARDS. Although the aetiology of non-pulmonary

ARDS is still elusive (with genetic, environmental and immunological components), the general hypothesis suggests that ARDS is caused by a circulatory MTD-induced cytoplasmic PPR

inflammatory response that leads to lung tissue damage. Cytoplasmic NLRP3 and IL-1_β_ is a key regulator of the immune response to DAMP. miR-223 has been shown to inhibit NLRP3 expression

_in vitro_, but its role in the NLRP3-mediated MTD-induced ALI process is unclear; therefore, understanding the molecular regulation of miRNA-223 during DAMP-induced injury may help improve

the treatment of non-pulmonary ARDS. In our study, miR-223 expression increased in the BALF of ARDS patients with non-infectious aetiologies (trauma and blood transfusion), and the

correlation was significant. Although the miR-223 in patients with ARDS caused by infection and inhalation was not significantly different from that in the control patients, there was a

positive linear relationship between the level of has-miR-223 in all patients with ARDS and the prognosis following conventional therapy. Thus, in this study, we focussed on the role of

miR-223 in the pathogenesis of MTD-induced acute ARDS. _In vivo_ experiments showed that MTDs induce hypoxemia, inflammatory and ALI in WT mice and the miR-223−/+ mice more sensitive to MTD

induction. In addition, MTDs upregulate miR-223 expression, which occurs after the onset of the inflammatory response, and therefore, miR-223 may be used as a negative feedback molecule to

alleviate MTD-induced ALI. We used X-rays to destroy the haematopoietic system of mice and found that WT and miR-223−/+ mice exhibited the opposite lung phenotype in response to MTD

induction after transplantation of the other’s BM. BM chimeric mice showed that the haematopoietic system is the source of increased miR-223 expression. Studies have shown that miR-223 is

least expressed in tissue-infiltrated macrophages but highly expressed in circulating monocytes and neutrophils.24, 36, 37, 38 According to the clinical data we collected, miR-223 levels

were positively correlated with LY6G+ cells in the lungs of patients with ARDS, whereas LY6G+ cells had a negative correlation with the prognosis of patients with ARDS, suggesting that LY6G+

cells may mediate the miR-223 mechanism of action. Therefore, we analysed the expression of miR-223 in the lung myeloid cell lineage. The results suggest that miR-223 deficiency leads to an

increase in Ly6G+ cells in the peripheral blood of mice. Detection of miR-223 expression in the sorted cells revealed that the increase in miR-223 induced by MTDs was mainly contributed by

Ly6G+ neutrophils, indicating that increased miR-223 will result in a decrease in the number of Ly6G+ neutrophils. Moreover, we examined the number of GMPs, which are the precursor

population of Ly6G+ neutrophils, in the BM, and the results suggested that miR-223 blocks the differentiation of GMPs into LyG+ neutrophils. Furthermore, BM chimeric mouse experiments showed

that miR-223 is essential for the differentiation of GMPs into Ly6G+ neutrophils. Further results showed that Ly6G antibody could block MTD-induced ALI and ARDS symptoms. These results

suggest that miR-223 can lead to a decrease in the number of peripheral Ly6G+ neutrophils, thereby alleviating MTD-induced ALI. Inflammatory cytokines, such as IL-1_β_, TNF-_α_, IL-6 and

IL-8, are increased in the BALF of ARDS patients.39 Our clinical data show that the miR-223 is negatively correlated with serum IL-1_β_ levels and that IL-1_β_ levels are negatively

correlated with the prognosis of ARDS patients. This suggests that downregulation of IL-1_β_ mediates the beneficial effect of miR-223 on ARDS recovery. It is interesting to note that

systemic immunosuppression has been observed in patients with non-pulmonary ARDS, and although there is a severe inflammatory response in the lungs, its potential underlying mechanism,

according to this study, is presumed that miR-223 expression inhibits the number of Ly6G+ cells in the circulation and leads to feedback immunosuppression. The results suggest that systemic

immunosuppression in patients with ARDS is dependent on the number of Ly6G+ cells and that MTDs induce the upregulation of miR-223 expression. In addition, MTDs significantly induce the

expression of multiple inflammatory cytokines and chemokines in the lungs, and miR-223 deficiency leads to increased cytokine release. Ly6G antibodies can effectively block the MTD-induced

release of cytokines, suggesting that Ly6G+ cells mediate a large amount of cytokine release. miRNA-223 is a haematopoietic cell-specific miRNA, and recent studies have shown that miR-223 is

almost exclusively expressed in myeloid cell lineage.31 miR-223 has a wide range of targeted inhibitory effects, including RHOB,40 FBXW7,41 FOXO42 and other important disease targets. _In

vitro_, NLRP3 has been shown to be inhibited by miR-22337 and has received widespread attention. Nevertheless, the regulatory role of miR-223 in MTD-induced ARDS is still unknown. Our

findings verified that miR-223 inhibited the expression of NLRP3 in BMDNs. In addition, the PAR-CLIP assay confirmed that the NLRP3 mRNA sequence was highly enriched in RISC after

stimulation with MTDs and that the enrichment process was enhanced and attenuated by miR-223 mimics and inhibitors, respectively. More importantly, the decrease in NLRP3 expression in the

BMDNs of WT mice is dependent on the upregulation of miR-223 and is time dependent after MTD stimulation. The expression of NLRP3 in the BMDNs of miR-223−/+ mice was not changed following

MTD induction. Meanwhile, the level of IL-1_β_ was consistent with the expression of NLRP3. This evidence suggests that miR-223 expression physiological feedback inhibits the MTD-induced

activation of the NLRP3 inflammasome. The current clinical treatments for ARDS include corticosteroid support therapy,43 recombinant colony-stimulating factor therapy,44 lipid metabolism

interference,45, 46 lung surface active agent therapy,47 _β_ agonist administration and NO inhalation.48, 49 However, only the use of neuromuscular blockers50 or mechanical ventilation51 can

improve mortality. Therefore, there is a lack of effective treatments to address the cause of complex ALI/ARDS. Our study evaluated the effect of pharmacological blockade of

miR-223–NLRP3–IL-1 on MTD-induced ALI, which resulted in better corrective efficacy. However, whether it can improve the mortality of patients with ARDS also requires further study. In

summary, our study highlights the key regulatory effect of Ly6G+ cells and the miR-223–NLRP3–IL-1_β_ pathway in MTD-induced ARDS. As illustrated in Figure 8, miR-223 feedback inhibits NLRP3

activation, inhibits early pulmonary inflammatory factor dysregulation and relieves MTD-induced ALI. Thus genetic or pharmacological modulation of the miR-223–NLRP3–IL-1_β_ pathway may be a

promising new treatment for MTD-induced ALI and ARDS. MATERIALS AND METHODS HUMAN SUBJECTS BALF was collected from human subjects at the intensive care unit of the Wannan Medical

College-affiliated Yijishan Hospital between January 2016 and March 2017. The Ethics Committee at the Yijishan Hospital of Wangnan Medical College approved all studies involving human

subjects, and written informed consent was obtained from all patients. The experimental procedures for human subjects were strictly enforced based on the 1983 Declaration of Helsinki.

Eligible ARDS patients were screened based on the Berlin definition.29 The basic data and risk factors of the patients are shown in Table 1. A total of 63 ARDS patients with different

aetiologies and healthy controls were included: 42 were male and 21 were female. ARDS patients had refractory hypoxemia, severe dyspnoea and cyanosis; their respiratory rate was >29

breaths/min. The PaO2/FiO2, lung BALF and serum biochemical indicators were monitored in real time. All patients were given PEEP for 4 days as well as rehydration and antibiotic drug

therapy. BALF or sub-lung level alveolar fluid was obtained by repeated sterile saline irrigation/lavage. ANIMALS miRNA-223−/+ mice and miRNA-223−/+ CD45.1+ mice on a C57BL/6J background

were a gift from Dr. Bo Xu (Director of the Shaanxi Provincial People’s Hospital at the Third Affiliated Hospital of Xi’an Jiaotong University). C57BL/6J (CD45.2) mice and wild-type mice

were purchased from Weitong Lihua Biotechnology (Beijing, China) (8–12-week old; 18–20 g, equal numbers of males and females) for subsequent experiments. Mice were housed in a

specific-pathogen-free environment at a temperature of 22–25 °C with a relative humidity of approximately 40%, daily 12 h day/night alternation and free access to food and drink. Animal

welfare and standard animal test procedures were strictly enforced based on the Guidelines for Laboratory Animal Care and Use (US National Research Council, 12 January 1996). Although

miR-223 expression was dependent on the X-chromosome, the physiological or pathological expression of miR-223 was not different (_P_>0.05) among the C57BL/6J background mice or ARDS

subjects. CONSTRUCTION OF THE BM CHIMERIC MOUSE MODEL BM chimeric mice were constructed using the method described by Zhou _et al._52 Briefly, following exposure to an X-ray dose of 5 Gy ×

2, miRNA223−/+ and WT-C57BL/6J mice received an intravenous administration of BM cells (approximately 4 × 106 cells) from miRNA223−/+ or WT-C57BL/6J mice not exposed to X-ray. The mice were

examined 3 weeks after transplantation. PREPARATION OF MTD-INDUCED LUNG INJURY MICE Mitochondrial granules were isolated from C57BL/6J mouse muscle tissue using a Beyotime Biotechnology Kit

(Beyotime Biotechnology, Shanghai, China) and suspended in 1 ml of Hank’s balanced salt solution buffer per 10 g of tissue. After the addition of protease inhibitor (1 : 100), the tissues

were exposed to ultrasonic vibration. The samples were centrifuged at 12 000 × _g_ for 10 min at 4 °C followed by centrifugation at 100 000 × _g_ for 30 min; then the supernatant, which

contained the MTDs, was collected. A BCA protein assay (Beyotime Biotechnology) was used to determine the protein concentration of the MTD solution. We used a 10 mg/kg intravenous injection

of MTDs to induce lung injury in mice. The entire MTDs preparation process was sterile. Limulus reagent (A&C Biological Ltd, Zhangjiang, China) was used to detect endotoxin levels

(<0.015 EU/ml). PCR was used to detect nuclear DNA content (<0.01%). The miRNA223−/+ mice and WT mice were divided into 7 groups (12 mice in each group). At 6, 12, 24, 48, 72 and 96 h

after intravenous injection of 10 mg/kg MTDs, the mice were fixed. PaO2/FiO2 levels were detected in the 0–72-h group. At the same time points, BALF was collected from half of the mice, and

the other half was used to measure the lung dry/wet weight ratio. For the 96-h group of mice, all lung tissue was used for haematoxylin and eosin (HE) staining (Solarbio Ltd, Beijing,

China). PAO2/FIO2, INFLAMMATORY CELL COUNTS IN THE BALF, THE LUNG DRY/WET RATIO AND LUNG INJURY PATHOLOGICAL EXAMINATION PaO2/FiO2 in mice was measured using an ABL800 blood gas analyser

(Radiometer, Copenhagen, Denmark). After the mice were killed, the lung tissue was stripped, and the surface water was rinsed with physiological saline. The wet weight was measured, and then

the lung tissues were dried at a constant temperature of 80 °C for 24 h. The dry weight was measured, and the lung dry/wet weight ratio was calculated. The necks of the mice were cut, and

the tissues surrounding the trachea were removed. Using a blunt syringe needle, the trachea was punctured, and the nose and mouth of the mice were connected to a 5-ml collector. The entire

bronchial bronchus was lavaged with prechilled phosphate-buffered saline for a total of three times. The neutrophils, lymphocytes and macrophages were pelleted from BALF by centrifugation

for 5 min at 25 °C. The total cell count was obtained using a 100 × oil objective in Wright’s solution (Sigma-Aldrich, Darmstadt, Germany). The mice were fixed under deep anaesthesia; 4 °C

prechilled heparin saline was used to irrigate the entire pulmonary circulatory system, removing the red blood cells after perfusion with 4% paraformaldehyde for internal fixation. All lung

tissue was removed and fixed in 4% paraformaldehyde solution for 24 h. Then the tissue was paraffin embedded, and sections were acquired and stained with HE for histopathological observation

(400 ×, Olympus, Tokyo, Japan). MIRNA DETECTION The relative quantity of 29 inflammation-related miRNAs was determined by Genepharma (Shanghai, China) using their small-scale prescreening

services. For the detection of miR-223, total miRNA was extracted from the BALF using the RNAeasy Small RNA Isolation Kit (Beyotime Biotechnology). Reverse transcription of miR-223 using a

specific stem-loop primer (GenePharma) was performed using qPCR with a TaqMan miRNA Assay Kit (Applied Biosystems, Waltham, MA, USA). U6 was used as an internal control. The miR-223 reverse

transcription primer was as follows: 5′-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAG AACTGTCA-3′. The miR-223 quantitative primers were as follows: forward primer

5′-ACACTCCAGCTGGGACCCCATAAACTGTTT-3′; and reverse primer: 5′-TGGTGTCGTGGAGTCG-3′. The U6 primers were as follows: 5′-CTCGCTTCGGCAGCACA-3′; and 5′-AACGCTTCACGAATTTGCGT-3′. DETECTION OF

INFLAMMATORY CYTOKINES Inflammatory cytokine and chemokines were screened using the mouse Inflammation Array G1 (Raybiotech Ltd, Guangzhou, China) antibody chip according to the

manufacturer’s instructions (≥1.5-fold increase or a decrease ≤0.65-fold indicates a significant difference). The sequences of the corresponding inflammatory cytokines are shown in

Supplementary Figure S3A. The detection of IL-1_β_ was performed using an ELISA kit (R&D Systems Inc., Minneapolis, MN, USA) according to manufacturer’s instructions. ISOLATION,

PURIFICATION AND LABELLING OF MOUSE BMDNS BMDNs were obtained following the method described by Swamydas and Lionakis53 Briefly, the miRNA223−/+ or WT-C57BL/6J mice were sterilized, and the

femurs and tibia were isolated and placed in a petri dish with ice-cold RPMI 1640 1 × containing 10% FBS and 1% penicillin/streptomycin. After cutting the bones, a syringe containing 10 ml

of RPMI supplemented with 10% FBS and 2 mM EDTA was used to rinse the femoral/tibial pair. The solution was passed through a 100-_μ_m filter. In addition, the sample was centrifuged at 1400

× _g_ for 7 min at 4 °C. Approximately 800 000 BM cells were harvested from each uninfected 8–12-week-old C57BL/6J mouse. Neutrophils were obtained by density gradient centrifugation.

Neutrophils were labelled with CD45 (clone 30-F11), Ly6G (clone 1A8) and CD11b (clone M1/70) (Abcam, Cambridge, UK), and they were sorted by flow cytometry for subsequent experiments. FLOW

CYTOMETRY Mouse peripheral blood, BALF and BM were centrifuged to remove cell debris and filtered through a 100-_μ_m filter to prepare a single-cell suspension. After adding 10 _μ_l of

specific fluorescent monoclonal antibody, the cells were stained in the dark for 15 min. Flow cytometry was used to detect and sort the cell subsets. MHC II (M5/114.15.2), CD11b (M1/70),

CD11c (N418), Ly6G (1A8), Ly6C (HK1.4), Sca-1 (D7), CD117 (ACK2), CD34 (RAM34) (Abcam) or the corresponding fluorescent dye-labelled streptavidin antibody was added to the cells. Cell

analysis was performed using Attune NxT flow cytometry (Thermo Fisher, Waltham, MA, USA). RRPL3 3′UTR, MIR-223 MIMICS AND MIR-223 INHIBITOR TRANSFECTION The pGL3-luc-NLRP3 3′UTR luciferase

reporter gene was constructed using the miRNA-binding target prediction website (http://www.targetscan.org/) to predict the possibility of miRNA-223 binding to the NLRP3 3′UTR.

PGL3-luc-NLRP3 3′UTR plasmid, pGL3-luc-NLRP3 3′UTRdelete plasmid, miR-223 mimics and miR-223 inhibitor were obtained from GenePharma. For cell transfections, 1 × 106 or 107 Ly6G+ BMDN were

seeded in 96- or 12-well plates, and plasmids and miRNAs were transfected using Lipofectamine 3000 (Thermo Fisher) according to the instruction manual. A multifunctional fluoroscopy unit

(Molecular Devices, Sunnyvale, CA, USA) was used to detect luciferase activity. MIR-223 ADMINISTRATION TO MICE _IN VIVO_ MCC950 and anakinra were purchased from MedChemExpress (Princeton,

NJ, USA) and administered intraperitoneally at 40 mg/kg/day to mice. miR-223 was administered as the synthesized mmu-miR-223 via a nanoparticle. MaxSuppressor _In Vivo_ RNA-LANCEr II (NLE)

(Bioscientific, Austin, TX, USA) was used according to the manufacturer’s instructions to administer 100 _μ_g/kg/day mmu-miR-22 mimics intravenously. PAR-CLIP ANALYSIS The enrichment of

miR-223 in RISC was detected using the method described by Llobet-Navas _et al._54 RISC consists of the Dicer enzyme, Argonaute protein, siRNA and other biological macromolecules. Briefly,

the cells were pretreated with 10 _μ_M 4-thioureidine (Sigma-Aldrich) and irradiated with UV (200 mJ/cm2) at 4 °C overnight. The cells were then lysed on ice for 20 min. Then the cells were

centrifuged at 12 000 × _g_ for 15 min, and the cell pellet was resuspended and immunoprecipitated overnight at 4 °C using G beads (Roche, Basel, Switzerland) and 10 _μ_l of anti-AGO2

antibody (Cell Signaling Technology Inc., Boston, MA, USA). The expression level of NRPL3 mRNA in the final precipitate was examined by qPCR, and GAPDH, B2M and RPL13A (Cell Signaling

Technology) were used as internal reference genes. WESTERN BLOTTING The same amount of cellular protein extract (20 _μ_l) from each sample was separated and transferred to a nitrocellulose

membrane (Beyotime Biotechnology) using 12% SDS-PAGE (Bio-Rad Inc., Hercules, CA, USA). Each membrane was incubated overnight at 4 °C with an antibody against NRPL3 (Abcam). The membrane was

then incubated with the appropriate fluorescence-conjugated secondary antibody (LI-COR, Lincoln, NE, USA) at room temperature for 2 h. Imaging was performed using the Odyssey Imaging System

(LI-COR). STATISTICAL ANALYSIS All data are shown as the mean±S.E.M. The data were analysed using Student’s _t_-test (*_P_<0.05 and **_P_<0.01). Statistical analyses and the plotting

of the data were performed using GraphPad Prism 6.0 (GraphPad Software Inc., La Jolla, USA). PUBLISHER’S NOTE Publisher’s Note: Springer Nature remains neutral with regard to jurisdictional

claims in published maps and institutional affiliations. REFERENCES * Katzenstein AL, Bloor CM, Leibow AA . Diffuse alveolar damage—the role of oxygen, shock, and related factors. A review.

_Am J Pathol_ 1976; 85: 209–228. CAS  PubMed  PubMed Central  Google Scholar  * Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F . One-year outcomes in

survivors of the acute respiratory distress syndrome. _N Engl J Med_ 2003; 348: 683–693. Article  Google Scholar  * Hotchkiss RS, Opal S . Immunotherapy for sepsisa new approach against an

ancient foe. _N Engl J Med_ 2010; 363: 87–89. Article  CAS  Google Scholar  * Matthay MA, Zimmerman GA . Acute lung injury and the acute respiratory distress syndrome: four decades of

inquiry into pathogenesis and rational management. _Am J Respir Cell Mol Biol_ 2005; 33: 319–327. Article  CAS  Google Scholar  * Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP,

Neff M _et al_. Incidence and outcomes of acute lung injury. _N Engl J Med_ 2005; 353: 1685–1693. Article  CAS  Google Scholar  * Mutlu GM, Budinger GR . Incidence and outcomes of acute lung

injury. _N Engl J Med_ 2006; 354: 416–417. Article  CAS  Google Scholar  * Kawai T, Akira S . The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

_Nat Immunol_ 2010; 11: 373–384. Article  CAS  Google Scholar  * Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y _et al_. Regulation of lung injury and repair by Toll-like receptors and

hyaluronan. _Nat Med_ 2005; 11: 1173–1179. Article  CAS  Google Scholar  * Morrison TJ, Jackson MV, Cunningham EK, Kissenpfennig A, McAuley DF, O'Kane CM _et al_. Mesenchymal stromal

cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. _Am J Respir Crit Care Med_ 2017; 196: 665–p12. Article  Google Scholar

  * Murray LA, Knight DA, McAlonan L, Argentieri R, Joshi A, Shaheen F _et al_. Deleterious role of TLR3 during hyperoxia-induced acute lung injury. _Am J Respir Crit Care Med_ 2008; 178:

1227–1237. Article  CAS  Google Scholar  * Barsness KA, Arcaroli J, Harken AH, Abraham E, Banerjee A, Reznikov L _et al_. Hemorrhage-induced acute lung injury is TLR-4 dependent. _Am J

Physiol Regul Integr Comp Physiol_ 2004; 287: R592–R599. Article  CAS  Google Scholar  * Franchi L, Munoz-Planillo R, Nunez G . Sensing and reacting to microbes through the inflammasomes.

_Nat Immunol_ 2012; 13: 325–332. Article  CAS  Google Scholar  * Liston A, Masters SL . Homeostasis-altering molecular processes as mechanisms of inflammasome activation. _Nat Rev Immunol_

2017; 17: 208–214. Article  CAS  Google Scholar  * Hauser CJ, Sursal T, Rodriguez EK, Appleton PT, Zhang Q, Itagaki K . Mitochondrial damage associated molecular patterns from femoral

reamings activate neutrophils through formyl peptide receptors and P44/42 MAP kinase. _J Orthop Trauma_ 2010; 24: 534–538. Article  Google Scholar  * Lee YL, King MB, Gonzalez RP, Brevard

SB, Frotan MA, Gillespie MN _et al_. Blood transfusion products contain mitochondrial DNA damage-associated molecular patterns: a potential effector of transfusion-related acute lung injury.

_J Surg Res_ 2014; 191: 286–289. Article  CAS  Google Scholar  * Ryu JK, Kim SJ, Rah SH, Kang JI, Jun HE, Lee D _et al_. Reconstruction of LPS transfer cascade reveals structural

determinants within LBP, CD14, and TLR4-MD2 for efficient LPS recognition and transfer. _Immunity_ 2017; 46: 38–50. Article  CAS  Google Scholar  * Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal

T, Junger W _et al_. Circulating mitochondrial DAMPs cause inflammatory responses to injury. _Nature_ 2010; 464: 104–107. Article  CAS  Google Scholar  * Ray NB, Durairaj L, Chen BB, McVerry

BJ, Ryan AJ, Donahoe M _et al_. Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia. _Nat Med_ 2010; 16: 1120–1127.

Article  CAS  Google Scholar  * Atkinson J, Kapralov AA, Yanamala N, Tyurina YY, Amoscato AA, Pearce L _et al_. A mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates

radiation-induced death. _Nat Commun_ 2011; 2: 497. Article  Google Scholar  * Zhao C, Itagaki K, Gupta A, Odom S, Sandler N, Hauser CJ . Mitochondrial damage-associated molecular patterns

released by abdominal trauma suppress pulmonary immune responses. _J Trauma Acute Care Surg_ 2014; 76: 1222–1227. Article  CAS  Google Scholar  * O'Connell RM, Rao DS, Chaudhuri AA,

Baltimore D . Physiological and pathological roles for microRNAs in the immune system. _Nat Rev Immunol_ 2010; 10: 111–122. Article  CAS  Google Scholar  * Eulalio A, Schulte L, Vogel J .

The mammalian microRNA response to bacterial infections. _RNA Biol_ 2012; 9: 742–750. Article  CAS  Google Scholar  * Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H _et al_. Essential

metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. _J Clin Invest_ 2012; 122: 2871–2883. Article  CAS  Google Scholar  * Johnnidis JB, Harris MH, Wheeler RT,

Stehling-Sun S, Lam MH, Kirak O _et al_. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. _Nature_ 2008; 451: 1125–1129. Article  CAS  Google Scholar  *

Dorhoi A, Iannaccone M, Farinacci M, Fae KC, Schreiber J, Moura-Alves P _et al_. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. _J Clin

Invest_ 2013; 123: 4836–4848. Article  CAS  Google Scholar  * Li T, Morgan MJ, Choksi S, Zhang Y, Kim YS, Liu ZG . MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway

by regulating expression of the kinase IKKalpha during macrophage differentiation. _Nat Immunol_ 2010; 11: 799–805. Article  CAS  Google Scholar  * Pulikkan JA, Dengler V, Peramangalam PS,

Peer Zada AA, Muller-Tidow C, Bohlander SK _et al_. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. _Blood_ 2010; 115:

1768–1778. Article  CAS  Google Scholar  * Haneklaus M, Gerlic M, O'Neill LA, Masters SL . miR-223: infection, inflammation and cancer. _J Intern Med_ 2013; 274: 215–226. Article  CAS

  Google Scholar  * Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E _et al_. Acute respiratory distress syndrome: the Berlin definition. _JAMA_ 2012; 307:

2526–2533. Google Scholar  * Chen CZ, Li L, Lodish HF, Bartel DP . MicroRNAs modulate hematopoietic lineage differentiation. _Science_ 2004; 303: 83–86. Article  CAS  Google Scholar  *

Friedman AD . Transcriptional control of granulocyte and monocyte development. _Oncogene_ 2007; 26: 6816–6828. Article  CAS  Google Scholar  * Buttenschoen K, Kornmann M, Berger D, Leder G,

Beger HG, Vasilescu C . Endotoxemia and endotoxin tolerance in patients with ARDS. _Langenbecks Arch Surg_ 2008; 393: 473–478. Article  Google Scholar  * Vermeij JD, Aslami H, Fluiter K,

Roelofs JJ, van den Bergh WM, Juffermans NP _et al_. Traumatic brain injury in rats induces lung injury and systemic immune suppression. _J Neurotrauma_ 2013; 30: 2073–2079. Article  Google

Scholar  * Lechner AJ, Tredway TL, Brink DS, Klein CA, Matuschak GM . Differential systemic and intrapulmonary TNF-alpha production in Candida sepsis during immunosuppression. _Am J Physiol_

1992; 263: L526–L535. CAS  PubMed  Google Scholar  * Bird MD, Kovacs EJ . Organ-specific inflammation following acute ethanol and burn injury. _J Leukoc Biol_ 2008; 84: 607–613. Article 

CAS  Google Scholar  * Bauernfeind F, Rieger A, Schildberg FA, Knolle PA, Schmid-Burgk JL, Hornung V . NLRP3 inflammasome activity is negatively controlled by miR-223. _J Immunol_ 2012; 189:

4175–4181. Article  CAS  Google Scholar  * Haneklaus M, Gerlic M, Kurowska-Stolarska M, Rainey AA, Pich D, McInnes IB _et al_. Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3

inflammasome and IL-1beta production. _J Immunol_ 2012; 189: 3795–3799. Article  CAS  Google Scholar  * Ramkissoon SH, Mainwaring LA, Ogasawara Y, Keyvanfar K, McCoy JP Jr, Sloand EM _et

al_. Hematopoietic-specific microRNA expression in human cells. _Leuk Res_ 2006; 30: 643–647. Article  CAS  Google Scholar  * Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE .

Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. _Chest_ 2009; 136: 1631–1643. Article  Google Scholar  * Zeng Y, Zhang X, Kang K,

Chen J, Wu Z, Huang J _et al_. MicroRNA-223 attenuates hypoxia-induced vascular remodeling by targeting RhoB/MLC2 in pulmonary arterial smooth muscle cells. _Sci Rep_ 2016; 6: 24900. Article

  CAS  Google Scholar  * He D, Huang C, Zhou Q, Liu D, Xiong L, Xiang H _et al_. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion. _Oncotarget_ 2017;

8: 20165–20178. CAS  PubMed  PubMed Central  Google Scholar  * Han BW, Feng DD, Li ZG, Luo XQ, Zhang H, Li XJ _et al_. A set of miRNAs that involve in the pathways of drug resistance and

leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL. _Hum Mol Genet_ 2011; 20: 4903–4915. Article  CAS  Google Scholar  *

Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A . Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. _BMJ_

2008; 336: 1006–1009. Article  Google Scholar  * Paine R 3rd, Standiford TJ, Dechert RE, Moss M, Martin GS, Rosenberg AL _et al_. A randomized trial of recombinant human

granulocyte-macrophage colony stimulating factor for patients with acute lung injury. _Crit Care Med_ 2012; 40: 90–97. Article  CAS  Google Scholar  * National Heart, Lung, and Blood

Institute ARDS Clinical Trials Network, Truwit JD, Bernard GR, Steingrub J, Matthay MA _et al_. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. _N Engl J Med_ 2014;

370: 2191–2200. Article  Google Scholar  * Rice TW, Wheeler AP, Thompson BT, deBoisblanc BP, Steingrub J, Rock P _et al_. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant

supplementation in acute lung injury. _JAMA_ 2011; 306: 1574–1581. Article  CAS  Google Scholar  * Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventos AA _et al_.

Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. _N Engl J Med_ 1996; 334: 1417–1421.

Article  CAS  Google Scholar  * National Heart, Lung, and Blood Institute ARDS Clinical Trials Network, Matthay MA, Brower RG, Carson S, Douglas IS _et al_. Randomized, placebo-controlled

clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. _Am J Respir Crit Care Med_ 2011; 184: 561–568. Article  Google Scholar  * Dellinger RP, Zimmerman JL,

Taylor RW, Straube RC, Hauser DL, Criner GJ _et al_. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled

nitric oxide in ARDS Study GROUP. _Crit Care Med_ 1998; 26: 15–23. Article  CAS  Google Scholar  * Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A _et al_. Neuromuscular

blockers in early acute respiratory distress syndrome. _N Engl J Med_ 2010; 363: 1107–1116. Article  CAS  Google Scholar  * Acute Respiratory Distress Syndrome Network, Brower RG, Matthay

MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress

syndrome. _N Engl J Med_ 2000; 342: 1301–1308. Article  Google Scholar  * Zhou H, Xiao J, Wu N, Liu C, Xu J, Liu F _et al_. MicroRNA-223 regulates the differentiation and function of

intestinal dendritic cells and macrophages by targeting C/EBPbeta. _Cell Rep_ 2015; 13: 1149–1160. Article  CAS  Google Scholar  * Swamydas M, Lionakis MS . Isolation, purification and

labeling of mice bone marrow neutrophils for functional studies and adoptive transfer experiments. _J Vis Exp_ 2013; 77: e50586. Google Scholar  * Llobet-Navas D, Rodriguez-Barrueco R, de la

Iglesia-Vicente J, Olivan M, Castro V, Saucedo-Cuevas L _et al_. The microRNA 424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by transforming growth factor beta

in mammary epithelial cells. _Mol Cell Biol_ 2014; 34: 4216–4231. Article  Google Scholar  Download references ACKNOWLEDGEMENTS We thank Dr. Bo Xu (Xi’an Jiaotong University) for kindly

providing us with miR-223−/+ mice and for the technical assistance with mouse BM transplantation. This work was supported by grants from the National Natural Science Foundation of China

(grant numbers 31301171, 81601380); the Natural Science Foundation of Anhui Province, China (grant number KJ2016SD59); Outstanding Young Talent Support Program Key Projects in Anhui Colleges

and Universities (grant number gxyqZD2016173) and the Natural Science Research Project in colleges and universities of Anhui Province (numbers KJ2016A734 and KJ2017A256) AUTHOR INFORMATION

AUTHORS AND AFFILIATIONS * Anhui Province Key Laboratory of Active Biological Macro-molecules, Wannan Medical College, Wuhu, China Zunyong Feng, Shimei Qi, Zhilin Qi, Liang Yan, Jing Zhou, 

Qiang Li & Yao Zhang * Department of Forensic Medicine, Wannan Medical College, Wuhu, China Zunyong Feng, Yue Zhang, Fang He, Qianqian Li, Yanyan Yang & Yang Chen * Department of

Biochemistry, Wannan Medical College, Wuhu, China Shimei Qi, Zhilin Qi, Liang Yan, Qiang Li & Yao Zhang * Department of Intensive Care Unit, Affiliated Yijishan Hospital of Wannan

Medical College, Wuhu, China Qun Chen & Shi Xiao Authors * Zunyong Feng View author publications You can also search for this author inPubMed Google Scholar * Shimei Qi View author

publications You can also search for this author inPubMed Google Scholar * Yue Zhang View author publications You can also search for this author inPubMed Google Scholar * Zhilin Qi View

author publications You can also search for this author inPubMed Google Scholar * Liang Yan View author publications You can also search for this author inPubMed Google Scholar * Jing Zhou

View author publications You can also search for this author inPubMed Google Scholar * Fang He View author publications You can also search for this author inPubMed Google Scholar * Qianqian

Li View author publications You can also search for this author inPubMed Google Scholar * Yanyan Yang View author publications You can also search for this author inPubMed Google Scholar *

Qun Chen View author publications You can also search for this author inPubMed Google Scholar * Shi Xiao View author publications You can also search for this author inPubMed Google Scholar

* Qiang Li View author publications You can also search for this author inPubMed Google Scholar * Yang Chen View author publications You can also search for this author inPubMed Google

Scholar * Yao Zhang View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHORS Correspondence to Yang Chen or Yao Zhang. ETHICS DECLARATIONS

COMPETING INTERESTS The authors declare no conflict of interest. ADDITIONAL INFORMATION Edited by H-U Simon Supplementary Information accompanies this paper on Cell Death and Disease website

SUPPLEMENTARY INFORMATION SUPPLEMENTARY FIGURE LEGENDS (DOCX 18 KB) SUPPLEMENTARY FIGURE S1 (JPG 159 KB) SUPPLEMENTARY FIGURE S2 (JPG 365 KB) SUPPLEMENTARY FIGURE S3 (JPG 152 KB) RIGHTS AND

PERMISSIONS _Cell Death and Disease_ is an open-access journal published by _Nature Publishing Group_. This work is licensed under a Creative Commons Attribution 4.0 International License.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not

included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit

http://creativecommons.org/licenses/by/4.0/ Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Feng, Z., Qi, S., Zhang, Y. _et al._ Ly6G+ neutrophil-derived miR-223 inhibits the

NLRP3 inflammasome in mitochondrial DAMP-induced acute lung injury. _Cell Death Dis_ 8, e3170 (2017). https://doi.org/10.1038/cddis.2017.549 Download citation * Received: 11 July 2017 *

Revised: 08 September 2017 * Accepted: 11 September 2017 * Published: 16 November 2017 * Issue Date: November 2017 * DOI: https://doi.org/10.1038/cddis.2017.549 SHARE THIS ARTICLE Anyone you

share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the

Springer Nature SharedIt content-sharing initiative